Pluristem is a clinical-stage biotherapy company using placental cells and a proprietary three-dimensional technology platform to develop cell therapies for conditions such as inflammation, ischemia, hematological disorders, or exposure to radiation....Show all
Company (IPO / Went public)
Phone: +972 747108600
MATAM Advanced Technology Park
Building #5
Haifa, 3508409
Israel
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Methods and systems for harvesting cells | May 15, 2017 | Dec 01, 2020 | Patent |
Altered adherent stromal cells and methods of producing and using same | Jun 06, 2016 | Dec 01, 2020 | Patent |
Methods for treating radiation or chemical injury | Jul 06, 2017 | Jul 28, 2020 | Patent |
Adherent cells from placenta and use of same in disease treatment | Aug 25, 2015 | Apr 07, 2020 | Patent |
Systems and methods for growing and harvesting cells | Mar 03, 2015 | Aug 27, 2019 | Patent |